⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Form 8-K
sec.gov
TENX
LNSR
BCRX
MRK
GILD
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)
businesswire.com
MRK
GILD
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda
globenewswire.com
MRK
BMY
GILD
TAK
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL USA - English USA - English
prnewswire.com
MRK
GSK
GILD
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL USA - English USA - English
prnewswire.com
MRK
GSK
GILD
Form 8-K
sec.gov
RCUS
GILD
New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
prnewswire.com
GILD
U.S. Chamber Discusses How Medical Breakthroughs Are Extending Lives and Strengthening the Economy with YourUpdateTV
globenewswire.com
MRK
PFE
JNJ
BMY
GILD
LLY
AMGN
REGN
ABBV
BIIB
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
prnewswire.com
GILD